Cancer Health Treatment Update FDA Approves Trodelvy for Most Common Type of Metastatic Breast Cancer The antibody-drug conjugate is now approved for patients with hormone receptor-positive/HER2-negative or triple-negative breast cancer. Melanoma at 33: A Testament to the Importance of Early Detection After skin cancer surgery, Matthew Ruiz completed a process known as Total Body Photography to track any changes over time. The Radical Compassion of Awake Brain Surgery On the operating table and inside the lab of a rising star in cancer neurosurgery. Advertisement Brukinsa’s Approval Improves Targeted Treatment for Leukemia Approved for CLL and SLL—types of leukemia and lymphoma—Brukinsa caused fewer heart-related side effects in trials. Cancer Health Winter 2023 Check out our latest print edition! Cancer Health now offers individual newsletters for people interested in specific cancer types. Get the latest cancer news tailored to your needs and interests delivered to your inbox. To update your preferences and start getting cancer-specific newsletters, please visit your personal preferences page. Lingering Symptoms Common After COVID Hospitalization Many adults experience problems like coughing, chest pain, and fatigue six months after their stay. More News About COVID-19 See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com. Newsfeed A New Way to Assess the Chance of Gastrointestinal Tumor Recurrence Blue Jacket Fashion Show Returns for Prostate Cancer Awareness One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity States Continue to Shortchange Tobacco Prevention Programs Blog: National Cancer Institute Help Desk for Oncologists Treating a Rare Leukemia Pays Big Dividends Brukinsa’s Approval Improves Targeted Treatment for Leukemia Doing More—Together—to End Cancer as We Know It Trial Suggests Expanded Role for Blinctyo in Treating Leukemia Newsfeed A New Way to Assess the Chance of Gastrointestinal Tumor Recurrence Blue Jacket Fashion Show Returns for Prostate Cancer Awareness One Year Anniversary of Cancer Moonshot Reignition Brings Progress and Opportunity States Continue to Shortchange Tobacco Prevention Programs Blog: National Cancer Institute Help Desk for Oncologists Treating a Rare Leukemia Pays Big Dividends Brukinsa’s Approval Improves Targeted Treatment for Leukemia Doing More—Together—to End Cancer as We Know It Trial Suggests Expanded Role for Blinctyo in Treating Leukemia

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: